117 related articles for article (PubMed ID: 36735765)
1. MiR-92a regulates PTEN/Akt signaling axis to promote paclitaxel resistance in ovarian cancer cells.
Deng X; Wu H; Xiong L; Wu M; Cao J; Liu J; Xie W
Acta Biochim Pol; 2023 Feb; 70(1):169-174. PubMed ID: 36735765
[TBL] [Abstract][Full Text] [Related]
2. miR-92a promotes proliferation and inhibits apoptosis of prostate cancer cells through the PTEN/Akt signaling pathway.
Yanshen Z; Lifen Y; Xilian W; Zhong D; Huihong M
Libyan J Med; 2021 Dec; 16(1):1971837. PubMed ID: 34431444
[TBL] [Abstract][Full Text] [Related]
3. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Yan H; Zhang HY; Zhou B
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4149-4155. PubMed ID: 31173285
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
5. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
6. MiR-130b can suppress proliferation of glioma cells through targeting PTEN to regulate AKT pathway.
Niu H; Liu Y; Wang Y; Tian Y; Jiang H; Cao S; Yang M; Li S
J BUON; 2020; 25(4):2059-2065. PubMed ID: 33099953
[TBL] [Abstract][Full Text] [Related]
7. MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway.
Ke TW; Wei PL; Yeh KT; Chen WT; Cheng YW
Ann Surg Oncol; 2015 Aug; 22(8):2649-55. PubMed ID: 25515201
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92a-3p enhances functional recovery and suppresses apoptosis after spinal cord injury via targeting phosphatase and tensin homolog.
He S; Wang Z; Li Y; Dong J; Xiang D; Ren L; Guo L; Shu J
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32297644
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
10. miR-92a promotes progesterone resistance in endometriosis through PTEN/AKT pathway.
Li M; Peng J; Shi Y; Sun P
Life Sci; 2020 Feb; 242():117190. PubMed ID: 31863773
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-29a facilitates apoptosis of colorectal carcinoma cell SW480 and suppresses its Paclitaxel resistance.
Yuan LL; Li L; Liu JN; Mei J; Lei CJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5499-5507. PubMed ID: 30229821
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA-9119 suppresses in ovarian cancer cell viability via targeting the microRNA-21-5p-PTEN-Akt pathway.
Gong J; Xu X; Zhang X; Zhou Y
Aging (Albany NY); 2020 Jul; 12(14):14314-14328. PubMed ID: 32675386
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-301a Promotes Cell Proliferation and Resistance to Apoptosis through PTEN/PI3K/Akt Signaling Pathway in Human Ovarian Cancer.
Ni J; Chen Y; Fei B; Zhu Y; Du Y; Liu L; Guo L; Zhu W
Gynecol Obstet Invest; 2021; 86(1-2):108-116. PubMed ID: 33596588
[TBL] [Abstract][Full Text] [Related]
14. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
Du G; Cao D; Meng L
Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
[TBL] [Abstract][Full Text] [Related]
15. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.
Chai C; Song LJ; Han SY; Li XQ; Li M
CNS Neurosci Ther; 2018 May; 24(5):369-380. PubMed ID: 29316313
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
Xia XY; Yu YJ; Ye F; Peng GY; Li YJ; Zhou XM
Neoplasma; 2020 Mar; 67(2):344-353. PubMed ID: 31973537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
